• Lopinavir Identified as a MERS-CoV Inhibitor in Drug Repurpo

  2026-06-17

  de Wilde et al. performed a systematic screen of FDA-approved drugs and identified Lopinavir (ABT-378) as one of four small molecules that inhibit MERS-CoV replication in cell culture. This finding highlights the translational potential of repurposing HIV protease inhibitors for emerging coronavirus threats and provides a framework for rapid antiviral research.

• CCK-8s Drives ANP Secretion via NOX4–PGC-1α–PPAR Signaling i

  2026-06-16

  This study demonstrates that sulfated cholecystokinin octapeptide (CCK-8s) directly promotes atrial natriuretic peptide (ANP) secretion in isolated beating rat atria through activation of the NOX4–PGC-1α–PPARα/PPARγ signaling cascade. The work advances our understanding of cardiac hormone regulation and provides mechanistic insight into the roles of reactive oxygen species and nuclear receptor pathways in cardiovascular function.

• Intestinal TM6SF2 Regulates Gut–Liver Axis in MASH Pathogene

  2026-06-16

  The reference study uncovers a critical protective role for intestinal TM6SF2 in preventing metabolic dysfunction-associated steatohepatitis (MASH) by maintaining gut barrier integrity and modulating lipid and microbiota signaling. These findings offer mechanistic insight into the gut–liver axis and highlight new intervention strategies targeting lysophosphatidic acid signaling and immune cell recruitment.

• Puerarin Drives Osteogenic Differentiation via Nitric Oxide

  2026-06-15

  This study reveals that puerarin significantly enhances osteogenic differentiation of rat dental follicle cells by activating the nitric oxide pathway. The findings suggest a targeted mechanism relevant for periodontal tissue regeneration and highlight the utility of nitric oxide synthase inhibition as a mechanistic probe.

• Lenalidomide (CC-5013): Reliable Solutions for Myeloma Resea

  2026-06-15

  This article addresses common laboratory challenges in cell viability and immune modulation assays, focusing on how Lenalidomide (CC-5013) (SKU A4211) offers reproducible, data-backed solutions. Learn how to optimize protocols, interpret results, and select reliable sources for your multiple myeloma research workflows.

• Bedaquiline: Diarylquinoline Antibiotic for MDR Tuberculosis

  2026-06-14

  Bedaquiline is a diarylquinoline antibiotic that targets Mycobacterium tuberculosis F1FO-ATP synthase with high specificity, making it a key agent against multi-drug resistant strains. Its unique mechanism also disrupts cancer stem cell energy metabolism. This article details its atomic mechanisms, evidence benchmarks, and integration into research workflows.

• MK-1775: Wee1 Kinase Inhibitor for Precision Cell Cycle Stud

  2026-06-13

  MK-1775, a highly selective Wee1 kinase inhibitor, unlocks precise control of the G2 DNA damage checkpoint, enabling sensitization of p53-deficient tumor cells to chemotherapeutics. This guide distills validated workflows, troubleshooting insights, and data-driven optimizations for translational cancer research.

• Sunitinib: Multi-Targeted RTK Inhibitor for Advanced Cancer

  2026-06-12

  Sunitinib empowers laboratory teams to dissect and disrupt receptor tyrosine kinase signaling across diverse cancer models, offering finely tuned apoptosis induction and cell cycle arrest. This guide translates cutting-edge research and real-world workflows into actionable protocols—helping you maximize reproducibility and interpretability in tumor angiogenesis and cell viability assays.

• EP4 Deficiency in Macrophages Accelerates Atherosclerosis vi

  2026-06-12

  This study uncovers the mechanistic role of macrophage EP4 receptor deficiency in accelerating atherosclerosis through enhanced CD36-mediated lipid uptake and M1 polarization. The findings highlight EP4 as a key regulator of foam cell formation and inflammatory macrophage profiles, offering insights into potential therapeutic targets for cardiovascular disease.

• Moxidectin: Mechanistic Insights and Translational Potential

  2026-06-11

  Explore the multifaceted role of moxidectin as a macrocyclic lactone anthelmintic in both veterinary parasitic worm control and innovative antifungal synergy. This article offers advanced mechanistic analysis and practical guidance distinct from existing guides.

• Autophagy–Metastasis Signature Predicts CRC Prognosis and Im

  2026-06-11

  Bai et al. (2026) present a validated prognostic risk signature integrating autophagy and liver metastasis genes in colorectal cancer. Their multi-cohort bioinformatics and experimental study reveals that this signature predicts tumor immune microenvironment remodeling and resistance to immunotherapy, offering new translational targets for precision oncology.

• High-Throughput Gastruloid Arrays Reveal Developmental Aberr

  2026-06-10

  Jan et al. (2025) present a microraft array platform enabling automated, large-scale phenotyping and sorting of human gastruloids. This technology advances the study of developmental heterogeneity and chromosomal abnormalities, with significant implications for early embryogenesis and disease modeling.

• GSK3 Inhibition as a Host-Directed Therapy for Tuberculosis

  2026-06-10

  The referenced iScience study identifies glycogen synthase kinase 3 (GSK3) as a crucial host factor for Mycobacterium tuberculosis (Mtb) survival in macrophages. Through genetic and pharmacological inhibition of GSK3, the authors demonstrate a host-directed therapeutic strategy that limits intracellular Mtb growth, offering a promising alternative to conventional antibiotics.

• In Vitro Drug Response Measurement: Insights from Fractional

  2026-06-09

  Schwartz's dissertation introduces a refined approach to evaluating anticancer drug responses by distinguishing between proliferative arrest and cell death in vitro. This nuanced methodology improves the interpretability of drug screening results and informs the design of combination therapies targeting cell cycle checkpoints like Wee1.

• Bafilomycin C1: Redefining Lysosomal pH Control in Cardiotox

  2026-06-09

  Discover how Bafilomycin C1, a potent vacuolar H+-ATPases inhibitor, enables precision control of lysosomal pH for advanced cardiotoxicity and autophagy assays. This article uniquely explores its role in high-content iPSC-derived phenotypic screens, grounded in cutting-edge deep learning research.

15018 records 1/1002 page Next 12345 下5页 Last page